{
    "clinical_study": {
        "@rank": "84047", 
        "arm_group": [
            {
                "arm_group_label": "Frozen Embryo Transfer with PGD", 
                "arm_group_type": "Experimental", 
                "description": "All embryos will be hatched on day 3. Patients will have hatching blastocysts (*) biopsied on day 5 or day 6, embryos will then be vitrified,  analyzed by NGS, and will have one or two euploid embryo(s) thawed and transferred on a FET cycle, before noon. If more than two euploid blastocysts are available the one(s) to be transferred will be selected based on morphology (*)."
            }, 
            {
                "arm_group_label": "Fresh Embryo Transfer with PGD", 
                "arm_group_type": "Experimental", 
                "description": "All embryos will be hatched on day 3. Patients will have hatching blastocysts (*) biopsied on day 5, analyzed by NGS, and will have one or two euploid embryo transferred on day 6, in the am. If more than two euploid blastocysts are available the one(s) to be transferred will be selected based on morphology (*). Any morulas developing to hatching blastocyst on day-6 will be also analyzed but vitrified for use in a future cycle."
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators propose to perform a clinical randomized trial to evaluate the effect of a\n      frozen-thawed embryo transfer and a fresh embryo transfer on pregnancy and implantation\n      rates; with the added benefit of a blastocyst biopsy and whole chromosome analysis by Next\n      Generation Sequencing (NGS)."
        }, 
        "brief_title": "Comparison of Frozen-thawed Embryo Transfers and Fresh Embryo Transfers With Whole Chromosome Analysis Using Next Generation Sequencing", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "detailed_description": {
            "textblock": "1. Fresh group: All embryos will be hatched on day 3. Patients will have hatching\n           blastocysts (*) biopsied on day 5, analyzed by NGS, and will have one or two euploid\n           embryo transferred on day 6, in the am. If more than two euploid blastocysts are\n           available the one(s) to be transferred will be selected based on morphology (*). Any\n           morulas developing to hatching blastocyst on day-6 will be also analyzed but vitrified\n           for use in a future cycle.\n\n        2. Frozen group: All embryos will be hatched on day 3. Patients will have hatching\n           blastocysts (*) biopsied on day 5 or day 6, embryos will then be vitrified,  analyzed\n           by NGS, and will have one or two euploid embryo(s) thawed and transferred on a FET\n           cycle, before noon. If more than two euploid blastocysts are available the one(s) to be\n           transferred will be selected based on morphology (*).\n\n      (*) Hatching blastocysts as described by Gardner and Schoolcraft (1999):"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria (pre-stimulation):\n\n          -  Age up to 42 years\n\n        Exclusion Criteria (pre-stimulation):\n\n          -  MESA and TESE patients\n\n          -  At least one partner carrier of a chromosomal abnormality\n\n          -  Egg donor cycle (sperm donor is acceptable)\n\n          -  Gender selection cycles\n\n          -  Thaw cycles\n\n          -  Any patient who cannot have a fresh embryo transfer\n\n          -  FSH above 12 or AMH less than 1"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "42 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "186", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02000349", 
            "org_study_id": "Reprogenetics-3.117"
        }, 
        "intervention": {
            "arm_group_label": [
                "Frozen Embryo Transfer with PGD", 
                "Fresh Embryo Transfer with PGD"
            ], 
            "description": "PGD using Next generation sequencing", 
            "intervention_name": "PGD", 
            "intervention_type": "Other", 
            "other_name": [
                "PGD (Preimplantation Genetic Diagnosis)", 
                "NGS (Next Generation Sequencing)"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "infertility", 
            "next generation sequencing"
        ], 
        "lastchanged_date": "December 9, 2013", 
        "location": {
            "contact": {
                "email": "andrea.h@portlandivf.net", 
                "last_name": "Andrea Hockman", 
                "phone": "503-274-4994", 
                "phone_ext": "4159"
            }, 
            "facility": {
                "address": {
                    "city": "Portland", 
                    "country": "United States", 
                    "state": "Oregon", 
                    "zip": "97210"
                }, 
                "name": "Reproductive Medicine Lab, LLC"
            }, 
            "investigator": {
                "last_name": "John Hesla, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "overall_official": {
            "affiliation": "Reprogenetics", 
            "last_name": "Santiago Munne, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "determining whether a frozen or a fresh embryo transfer will improve implantation rate.", 
            "measure": "Implantation rate", 
            "safety_issue": "No", 
            "time_frame": "8 weeks after replacement"
        }, 
        "reference": [
            {
                "PMID": "3384119", 
                "citation": "Cohen J, DeVane GW, Elsner CW, Kort HI, Massey JB, Norbury SE. Cryopreserved zygotes and embryos and endocrinologic factors in the replacement cycle. Fertil Steril. 1988 Jul;50(1):61-7."
            }, 
            {
                "PMID": "17141767", 
                "citation": "Cohen J, Wells D, Munn\u00e9 S. Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates. Fertil Steril. 2007 Mar;87(3):496-503. Epub 2006 Dec 4."
            }, 
            {
                "PMID": "19773223", 
                "citation": "De Vos A, Staessen C, De Rycke M, Verpoest W, Haentjens P, Devroey P, Liebaers I, Van de Velde H. Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers. Hum Reprod. 2009 Dec;24(12):2988-96. Epub 2009 Sep 21."
            }, 
            {
                "PMID": "17094975", 
                "citation": "Sagoskin AW, Levy MJ, Tucker MJ, Richter KS, Widra EA. Laser assisted hatching in good prognosis patients undergoing in vitro fertilization-embryo transfer: a randomized controlled trial. Fertil Steril. 2007 Feb;87(2):283-7. Epub 2006 Nov 13."
            }, 
            {
                "citation": "Gardner DK and Schoolcraft WB. In vitro culture of human blastocysts. In: Jansen R, Mortimer D. eds. Towards Reproductive Certainty: Fertility and Genetics Beyond 1999. Carnforth, Parthenon Publishin, 1999, 378-88"
            }, 
            {
                "PMID": "20971462", 
                "citation": "Guti\u00e9rrez-Mateo C, Colls P, S\u00e1nchez-Garc\u00eda J, Escudero T, Prates R, Ketterson K, Wells D, Munn\u00e9 S. Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. Fertil Steril. 2011 Mar 1;95(3):953-8. Epub 2010 Oct 25."
            }, 
            {
                "PMID": "19409550", 
                "citation": "Munn\u00e9 S, Wells D, Cohen J. Technology requirements for preimplantation genetic diagnosis to improve assisted reproduction outcomes. Fertil Steril. 2010 Jul;94(2):408-30. Epub 2009 May 5. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02000349"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The second aim of this study is to determine retrospectively if mt DNA content is linked to implantation potential and if that is measurable by NGS. NGS provides the additional advantage that it can measure mitochondrial DNA, which it's content, seems to be inversely correlated with implantation (Fragouli et al 2013, ASRM).", 
            "measure": "Correlation of Mitochondrial DNA and implantation", 
            "safety_issue": "No", 
            "time_frame": "When a fetal heartbeat is detected (8 weeks after implantation)"
        }, 
        "source": "Reprogenetics", 
        "sponsors": {
            "collaborator": {
                "agency": "Reproductive Medicine Lab, LLC", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Reprogenetics", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}